共 10 条
[1]
MK 0 966,aspecificCOX 2inhibitor,hasclinicalefficacycomparabletodiclofenacinthetreatmentofkneeandhipOAina 2 6weekcontrolledclinicaltrial. CannonG,CaldwellJ,HoltP,etal. Arthritis and Rheumatism . 1998
[2]
Renaleffectsofse lectivecyclooxygenase 2inhibitioninnormotensivesalt depletedsubjects. RossatJ,MaillardM,NussbergerJ,etal. Clinical Pharmacology and Therapeutics . 1999
[3]
MK 0 966,aspecificCOX 2inhibitorshasclinicalefficacycomparabletoibuprofeninthetreatmentofkneeandhipOAinasix weekcontrolledclinicaltrial. SaagK,FisherC,MckayJ,etal. Arthritis and Rheumatism . 1998
[4]
Rofecoxib ,aspecif iccyclooxygenase 2inhibitor,inprimarydysmenorrhea :aran domizedcontrolledtrial. MorrisonBW,DanielsSE,KoteyP,etal. Obstetrics and Gynecology . 1999
[5]
SelectiveCOX 2inhibitorreceivesmarketingapproval. MillerJL. AmJHealth SystPharm . 1999
[6]
Clinicalexperiencewithcyclooxygenase 2inhibitors. RynJV,PairetM. Inflammation Research . 1999
[7]
COX 2inhibitors. HawkeyCJ. The Lancet . 1999
[8]
Newdrugoverview :Rofecoxib. Merck. AmJHealth SystPharm . 1999
[9]
Characterizationofrofecoxibasacyclooxygenase 2isoforminhibitoranddemonstra tionofanalgesiainthedentalmodel. EhrichEW,DallobA,LepeleireID,etal. Clinical Pharmacology and Therapeutics . 1999
[10]
Arandomizedtrialcompar ingtheeffectofrofecoxib ,acyclooxygenase 2specificinhibitor ,withthatofibuprofenonthegastroduodenalmucosaofpatientswithosteoarthritis. LaineL,HarperS,SimonT,etal. Gastroenterology . 1999